Prenatal therapy for fetal growth restriction

Clinical Obstetrics and Gynecology

Volumn 49, Issue 2, 2006, Pages 308-319

  Figueroa, Reinaldo ^a,b   Maulik, Dev ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Bed rest; Fetal growth restriction therapy; Low dose aspirin; Nitric oxide donors; Nutritional supplementation; Oxygen administration

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; FISH OIL; FLUNARIZINE; FOLIC ACID; GLYCEROL NITRATE; MAGNESIUM; NITRIC OXIDE DONOR; PLASMA SUBSTITUTE; RITODRINE; ZINC;

BED REST; CALCIUM INTAKE; CALORIC INTAKE; CLINICAL TRIAL; DECOMPRESSION; DIET RESTRICTION; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; ENZYME INACTIVATION; FETUS; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; HYPEROXIA; HYPOXEMIA; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE PRESSURE; IRON THERAPY; LOW DRUG DOSE; MATERNAL NUTRITION; OBESITY; OXYGEN THERAPY; PLACENTA CIRCULATION; PREECLAMPSIA; PRENATAL CARE; PROTEIN DIET; PROTEIN INTAKE; REVIEW; SODIUM RESTRICTION; THROMBOEMBOLISM; UTERUS CONTRACTION; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

ADRENERGIC BETA-AGONISTS; ASPIRIN; BED REST; CALCIUM CHANNEL BLOCKERS; CALCIUM, DIETARY; DIET, SODIUM-RESTRICTED; DIETARY SUPPLEMENTS; FEMALE; FETAL GROWTH RETARDATION; FISH OILS; FOLIC ACID; HUMANS; IRON COMPOUNDS; LOWER BODY NEGATIVE PRESSURE; MAGNESIUM COMPOUNDS; META-ANALYSIS AS TOPIC; NITRIC OXIDE DONORS; NUTRITIONAL SUPPORT; OXYGEN INHALATION THERAPY; PLASMA SUBSTITUTES; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMINS; ZINC COMPOUNDS;

EID: 33748253252     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200606000-00012     Document Type: Review

References (31)

1. Say L, Gulmezoglu AM, Hofmeyr GJ. Bed rest in hospital for suspected impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
2. Kovacevich GJ, Gaich SA, Lavin JP, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;182:1089-1092.
3. Heaman M, Gupton A. Perceptions of bed rest by women with high-risk pregnancies: a comparison between home and hospital. Birth. 1998;25:252-258.
4. Soothill PW, Nicolaides KH, Campbell S. Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. Br Med J. 1987;294:1051-1053.
5. Nicolaides KH, Campbell S, Bradley RJ, et al. Maternal oxygen therapy for intrauterine growth retardation. Lancet. 1987;1:942-945.
6. Say L, Gulmezoglu AM, Hofmeyr GJ. Maternal oxygen administration for suspected impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
7. Harding JE, Owens JA, Robinson JS. Should we try to supplement the growth retarded fetus? A cautionary tale. Br J Obstet Gynaecol. 1992;99:707-710.
8. 2 therapy and bedrest on fetuses with absent end-diastolic flow on umbilical artery Doppler waveform analysis. Br J Obstet Gynaecol. 1995;102:662-665.
9. Villar J, Khoury MJ, Finucane FF, et al. Differences in the epidemiology of prematurity and intrauterine growth retardation. Early Hum Dev. 1986;14:307-320.
10. Say l, Gulmezoglu AM, Hofmeyr GJ. Maternal nutrient supplementation for suspected impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
11. Kramer MS, Kakuma R. Energy and protein intake in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
12. Duley L, Henderson-Smart D. Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
13. Atallah AN, Hofmeyr GJ, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
14. Mahomed K. Folate supplementation in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
15. Mahomed K. Iron supplementation in pregnancy. (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
16. Cuervo LG, Mahomed K. Treatments for iron deficiency anaemia in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
17. Mahomed K. Iron and folate supplementation in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
18. Makrides M, Crowther CA. Magnesium supplementation in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
19. Mahomed K. Zinc supplementation in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
20. Mahomed K, Gulmezoglu AM. Vitamin D supplementation in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
21. Duley L. Prophylactic fish oil in pregnancy. In: Enin MW, Keirse MJ, Renfrew MJ, Neilson JP, eds. Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. London: British Medical Journal Publishing Group; 1995.
22. Merialdi M, Carroli G, Villar J, et al. Nutritional interventions during pregnancy for the prevention or treatment of impaired fetal growth: an overview of randomized controlled trials. J Nutr. 2003;133:1626S-1631S.
23. Leitich H, Egarter C, Husslein P, et al. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol. 1997;104:450-459.
24. Kozer E, Costei AM, Boskovic R, et al. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res Part B Dev Reprod Toxicol. 2003;68:70-84.
25. Say L, Gulmezoglu AM, Hofmeyr GJ. Betamimetics for suspected impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
26. Say L, Gulmezoglu AM, Hofmeyr GJ. Calcium channel blockers for potential impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
27. Say L, Gulmezoglu AM, Hofmeyr GJ. Plasma volume expansion for suspected impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
28. Hofmeyr GJ. Should abdominal decompression be consigned to the history books? Br J Obstet Gynaecol. 1990;97:467-469.
29. Hofmeyr GJ. Abdominal decompression for suspected fetal compromise/preeclampsia (Systematic Review). Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev. 2005;3. Oxford: Update Software.
30. Di Renzo GC, Luzi G. Management of intrauterine growth retardation. In: Chervenak FA, Kurjak A, eds. Current Perspectives on the Fetus as a Patient. New York: Parthenon; 1996:527-538.
31. Sieroszewski P, Suzin J, Karowicz-Bilinska A. Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine). J Matern-Fetal Neonat Med. 2004;15:363-366.